TME Pharma N.V. (Euronext Growth Paris: ALTME), a clinical-stage biotechnology company focused on developing novel therapies for treatment of cancer by targeting the tumor microenvironment (TME), ...

To examine the association between hormone therapy use and glioma risk, researchers analyzed data from 75,335 women aged 50-78 years in the Prostate, Lung, Colorectal and Ovarian (PLCO ...

The Mark Foundation for Cancer Research is proud to announce the recipients of the 2025 Emerging Leader Awards, recognizing five outstanding early-career scientists dedicated to revolutionizing cancer ...

key processes that control tumor growth. Researchers demonstrated these epigenetic changes in human cells and mouse models, highlighting fiber's systemic impact on health. Researchers have identified ...

We are an interdisciplinary group that studies areas related to clinical brain tumor research with a broad focus, both in terms of area and methodology. We conduct research in all stages of patient ...

While many of these lumps and bumps are harmless growths and considered benign, others could be harbingers of a more serious problem, such as cancer. The word tumor is an umbrella term for a ...

compared with higher-grade tumors, so they often have better outcomes. Low-grade gliomas are tumors that start in the glial cells in the brain, which support neuron function. Gliomas are ...

1MOE Key Laboratory of Gene Function and Regulation, Guangdong Province Key Laboratory of Pharmaceutical Functional Genes, School of Life Sciences, State Key Laboratory of Oncology in South China, Sun ...

High-risk multiple myeloma is genomically unstable, comprising heterogeneous populations of tumor cells that evolve over time. Light chain escape (LCE) is a clinical phenomenon observed when light ...

As a parent, you may feel a number of emotions when you learn that your child has a pediatric low-grade glioma (pLGG), a type of slow-growing, cancerous brain or spinal tumor that can develop in ...